the Image

Clinical Trial Details

If you are a patient or a caregiver and would like to learn more our cancer clinical trials call toll-free 1-855-702-8222 (adult trials) or 1-773-702-6808 (pediatric trials) or email .

Share this:
Brief Title Epacadostat and Pembrolizumab in Patients With Head and Neck Cancer That Have Failed Prior Immunotherapy
Official Title A Phase II Study of Epacadostat + Pembrolizumab in Head and Neck Cancer Patients, Who Failed Prior PD-1/PD-L1 Therapy
Principal Investigator Seiwert, Tanguy
Brief Summary Study to determine response rate of the combination of pembrolizumab plus epacadostat in patients with head and neck cancers that have received prior immunotherapy.
Gender All
Ages 18 Years
Enrollment 30
Accepts Healthy Volunteers No
Lead Sponsor University of ChicagoOther
Study Design
Study Phase Phase 2
Study Type Interventional
Contact Name Tanguy Seiwert, MD
Contact Phone 1-855-702-8222 (adult trials) or 1-773-702-6808 (pediatric trials)
Condition Head and Neck Squamous Cell Carcinoma
Detail for Health Professional (on
More clinical trials by this PI